July 2, 2026
9:58 pm

Life Settlement vs. Accelerated Death Benefit

An accelerated death benefit (ADB) lets a seriously ill policyholder collect part of their own death benefit early from the insurance company, while a life settlement sells the entire policy to a third-party buyer for a lump sum — typically 10–35% of face value. The ADB is faster and requires a qualifying diagnosis such as terminal, chronic, or critical illness; the settlement is open to a wider range of policyholders, can apply to the full policy value, and creates competition among bidders rather than a single insurer-set formula. Each route reduces or eliminates what your beneficiaries ultimately receive, and each carries distinct tax and benefit-eligibility consequences.

This guide compares the two options head to head — triggers, payout math, taxes, Medicaid impact, and the situations where each clearly wins.

In This Article

What an Accelerated Death Benefit Rider Actually Provides
The Three Common Triggers: Terminal, Chronic, and Critical Illness
How ADB Payouts Are Calculated — and Why They Are Discounted
How a Life Settlement — or Viatical Settlement — Works Differently
Eligibility Side by Side: Which Doors Are Open to You?
Tax Treatment: IRC 101(g) vs. the Rev. Rul. 2009-13 Tiers
Medicaid, SSI, and Other Benefit Programs: The Overlooked Variable
Choosing Between Them: Scenarios Where Each Option Wins
Frequently Asked Questions

Life Settlement vs. Accelerated Death Benefit

What an Accelerated Death Benefit Rider Actually Provides

An accelerated death benefit is a policy provision — sometimes a built-in feature, sometimes a rider added for a small charge or activation fee — that allows the insurer to advance a portion of the death benefit to the policyholder while the insured is still living, once a qualifying medical event occurs. It is your own money arriving early: whatever is accelerated, plus any interest or discount the insurer applies, is subtracted from what beneficiaries receive at death.

Key characteristics to understand:

It stays inside your existing contract. No third party is involved. You deal only with your insurance company, on terms fixed by the rider language.
Caps apply. Most riders limit acceleration to a percentage of the face amount — commonly 25% to 75%, sometimes up to 95% for terminal illness — and many impose dollar maximums.
The remaining policy usually continues. After a partial acceleration, a reduced death benefit stays in force, often with proportionally reduced premiums, though some chronic-illness designs reduce the benefit dollar-for-dollar plus charges.
Medical proof is required. A physician must certify the qualifying condition, and the insurer’s own medical reviewers evaluate the claim.

ADB riders became widespread in the 1990s, in part as insurers’ answer to the viatical settlement industry that had emerged during the AIDS crisis. Today the majority of individual life policies include some form of acceleration for terminal illness at no extra premium. If you are unsure what your policy contains, request the rider pages and a current in-force illustration — our accelerated death benefit guide explains how to read them.

The Three Common Triggers: Terminal, Chronic, and Critical Illness

Not all ADB riders open the same doors. The trigger definitions determine whether you can use the benefit at all, so start there.

Terminal illness acceleration. The classic version: a physician certifies a life expectancy below a stated threshold — most commonly 12 months, sometimes 24. Payout percentages are highest here, and the discount applied is smallest because the insurer expects to pay the full claim soon anyway.

Chronic illness acceleration. Triggered when the insured cannot perform two or more activities of daily living (bathing, dressing, eating, toileting, transferring, continence) or suffers severe cognitive impairment — essentially the long-term-care trigger under federal law. Benefits are often paid in installments subject to annual limits rather than one lump sum, and dollar-for-dollar versus discounted designs vary widely.

Critical illness acceleration. Triggered by a specified diagnosis — heart attack, stroke, invasive cancer, organ failure, ALS, and similar. Payouts are typically smaller percentages and the qualifying event list is exhaustive: if your condition is not on it, no benefit.

Two practical warnings. First, the definitions are strict and insurer-interpreted; “chronically ill” in marketing materials and “chronically ill” in rider language can diverge sharply. Second, many riders sold as “living benefits” on newer policies use a discounted acceleration method in which the insurer decides the payout at claim time based on your reduced life expectancy — meaning the amount is unknown until you apply. A life settlement, by contrast, does not depend on any contractual trigger: qualification rests on age, health, and policy economics, as detailed in who qualifies for a life settlement.

How ADB Payouts Are Calculated — and Why They Are Discounted

Policyholders are often surprised that accelerating $100,000 of death benefit does not produce a $100,000 check. Insurers use one of several methods to account for the fact that they are paying early:

Discount method. The insurer pays the present value of the accelerated amount, discounted from your certified life expectancy at an interest rate set in the rider. Shorter life expectancy means a smaller discount; a terminal claim with a 6-month prognosis might pay 90–95 cents on the dollar, while a chronic claim with a multi-year expectancy might pay substantially less.
Lien method. The insurer advances funds as a lien against the policy; interest accrues on the lien, and at death the benefit is reduced by the advance plus accumulated interest.
Dollar-for-dollar with fees. Some riders reduce the face amount exactly by the acceleration, minus an administrative fee, with premiums reduced proportionally.

Whatever the method, the insurer sets the number unilaterally under the contract formula — there is no negotiation and no competing bid. A life settlement flips that dynamic: licensed providers backed by institutional capital bid against one another, pricing the policy through discounted cash flow on independent life expectancy reports. The GAO’s report on life settlements documented that sellers historically received multiples of surrender value. Neither route guarantees which pays more in your case — a terminal-illness ADB on a short prognosis is very hard to beat — but for chronic conditions or longer prognoses, market bidding frequently produces a larger number than the rider formula. Learning how to shop and compare real offers lets you test both sides with actual figures rather than assumptions.

How a Life Settlement — or Viatical Settlement — Works Differently

A life settlement is the sale of the entire policy to a licensed third-party provider: you receive a lump sum, the buyer takes over all premiums, and the buyer collects the full death benefit at the insured’s passing. When the insured is terminally or chronically ill — generally a life expectancy under 24 months — the transaction is classified as a viatical settlement, a distinction that matters enormously for taxes, as covered below and in our complete viatical settlement guide.

Differences from an ADB that drive the decision:

No diagnosis trigger required. A healthy-ish 78-year-old with an unneeded policy can sell; no rider language or physician certification of terminal status is needed. Typical criteria: age 65+, face amount around $100,000+, policy in force 2+ years.
The whole policy is monetized. ADB riders cap acceleration at a fraction of face value; a settlement prices 100% of the death benefit into the offer.
Premiums end entirely. After an ADB partial acceleration you generally keep paying (reduced) premiums; after a settlement the buyer pays everything.
Competition sets the price. Multiple providers bid; the rider formula involves exactly one counterparty.
Regulation is state-based. Most states license providers and brokers under frameworks modeled on the NAIC Life Settlements Model Act, with rescission windows of 15–30 days.

The cost is finality: your beneficiaries receive nothing from a sold policy, while a partially accelerated policy still leaves them the remainder. The process is also slower — typically 60–120 days versus a few weeks for many ADB claims.

Factor	Accelerated Death Benefit	Life Settlement
Who pays you	Your own insurance company	Licensed third-party provider (institutional capital)
Eligibility trigger	Certified terminal, chronic, or critical illness per rider terms	Age/health/policy economics — generally 65+, $100k+ face, in force 2+ years; no diagnosis trigger required
Amount available	Capped portion of face value (often 25–95%), discounted or lien-based	Offer on full policy, typically 10–35% of face value via competitive bids
Remaining benefit for heirs	Reduced death benefit usually stays in force	None — buyer collects entire death benefit
Future premiums	Usually continue, often reduced proportionally	Eliminated — buyer assumes them
Speed	Often weeks for terminal claims	Typically 60–120 days
Tax treatment	Generally tax-free under IRC 101(g) if terminal; chronic within LTC limits	Three-tier under Rev. Rul. 2009-13; tax-free as viatical if terminally ill and provider is licensed
Price discovery	Single insurer formula, non-negotiable	Multiple bidders compete; offers can be shopped

How a Life Settlement — or Viatical Settlement — Works Differently

Eligibility Side by Side: Which Doors Are Open to You?

Before comparing dollar amounts, check which options you can actually use — many policyholders discover only one door is open.

You may only be able to use an ADB if: your policy is small (settlement buyers generally want $100,000+ face), the policy is very new (most states restrict settlements during the first two policy years), or you are younger with a qualifying illness but the policy type or size does not attract buyers. The rider is also the only same-week option — some terminal claims pay within weeks, which matters when time is short.

You may only be able to use a settlement if: your policy simply has no ADB rider or its triggers do not fit your situation. This is common: a 74-year-old with COPD, diabetes, and heart disease may be far too healthy for a terminal-illness rider yet exactly the profile that draws strong settlement bids. Term policies are another case — riders on term coverage are often limited, but a convertible term policy can be sold, a comparison with its own trade-offs.

Both doors open. A seriously ill insured with a sizable, seasoned permanent policy usually qualifies for both — and should price both. Request the insurer’s ADB quote in writing (the exact payout under the rider formula) while simultaneously soliciting settlement offers. The comparison costs nothing, and the numbers frequently differ by tens of thousands of dollars in one direction or the other. Sequencing matters too: accelerating first shrinks the death benefit and typically lowers subsequent settlement offers, so gather both quotes before triggering either.

Tax Treatment: IRC 101(g) vs. the Rev. Rul. 2009-13 Tiers

Taxes can swing this comparison, and the two options are governed by different rules.

Accelerated death benefits. Under Internal Revenue Code Section 101(g), amounts received under a life insurance contract on the life of a terminally ill individual — certified life expectancy of 24 months or less — are treated as death benefits and are generally excluded from income entirely. Chronically ill accelerations can also be tax-free, but only within limits: payments must generally be used for qualified long-term-care costs or fall under the per-diem cap that the IRS adjusts annually. Critical-illness lump sums under some rider designs may not enjoy the same exclusion. Details are published at IRS.gov.

Life settlements. Proceeds follow the three-tier framework of Rev. Rul. 2009-13 as modified by the 2017 tax act: recovery of basis is tax-free, gain up to the cash surrender value is ordinary income, and the excess is capital gain. Our tax treatment guide walks through worked examples.

The crucial exception — viatical settlements. Section 101(g) extends the same death-benefit exclusion to amounts received from a licensed viatical settlement provider when the insured is terminally ill (and, within LTC limits, chronically ill). In plain terms: a terminally ill policyholder can often sell to a third party and receive the proceeds income-tax-free, capturing market pricing with ADB-style tax treatment. Provider licensing requirements must be met for the exclusion to apply, which is one more reason to work only with licensed parties and to confirm the numbers with a tax professional before closing.

Medicaid, SSI, and Other Benefit Programs: The Overlooked Variable

For seniors on or approaching means-tested benefits, the eligibility impact of either option can outweigh the headline payout.

Both options create countable resources. Whether the cash arrives from your insurer as an acceleration or from a buyer as settlement proceeds, money sitting in your bank account above program limits can suspend Medicaid or Supplemental Security Income eligibility. SSI’s resource limit remains a few thousand dollars, and Medicaid long-term-care programs apply strict asset and look-back rules administered state by state.

Timing and structure matter. Chronic-illness ADB payments applied directly to qualified long-term-care expenses, or structured as periodic payments, may pass through without accumulating as a countable asset — while a single large lump sum almost certainly counts. Similarly, settlement proceeds spent down on care, or in some states directed into compliant arrangements, are treated differently than idle cash. A handful of states have explored programs allowing policy sale proceeds to fund Medicaid-qualified long-term-care spend-downs.

Veterans and other programs. VA pension benefits with asset tests (such as Aid and Attendance, described at VA.gov) raise parallel issues, as do subsidized housing and utility programs.

None of this means a policyholder receiving benefits cannot use either option — it means the decision should be sequenced with an elder-law attorney or benefits counselor first. It is far easier to plan the receipt of funds correctly than to unwind an eligibility loss afterward. If preserving benefits is paramount and the policy is modest, other alternatives may fit better than either acceleration or sale.

Choosing Between Them: Scenarios Where Each Option Wins

Pulling the threads together, the pattern of winners looks like this.

The ADB tends to win when:

Life expectancy is very short and certified — the rider’s discount shrinks toward zero, the claim pays within weeks, and 101(g) makes it tax-free.
You want to leave the remainder of the death benefit to beneficiaries — partial acceleration preserves the rest; a sale preserves nothing.
The policy is too small, too new, or otherwise unattractive to settlement buyers.
Speed is the controlling factor — hospice-stage needs cannot wait 60–120 days for a settlement to close.

The life settlement tends to win when:

Your condition is chronic or your prognosis is measured in years — rider formulas discount heavily or exclude you, while the bidding market prices your policy on its full economics.
The rider caps acceleration well below what you need, or your policy has no usable rider at all.
You want premiums gone entirely, not merely reduced.
You are terminally ill and a licensed viatical purchase would pay more than the insurer’s formula — with the same tax-free treatment.

In every case: get both numbers in writing before triggering either, since accelerating first depresses settlement value; involve tax and benefits advisors; and remember that both choices permanently reduce what heirs receive. If you are still weighing whether monetizing the policy makes sense at all, start with whether a life settlement is right for you — the honest answer for some policyholders is to keep the policy untouched.

Frequently Asked Questions

Is an accelerated death benefit the same thing as a viatical settlement?

No, though they serve similar people. An accelerated death benefit is paid by your own insurance company under a rider in your existing policy — no ownership change occurs, and beneficiaries keep whatever portion is not accelerated. A viatical settlement is the sale of the entire policy to a licensed third-party provider when the insured is terminally or chronically ill; ownership transfers and the buyer collects the full death benefit. Both can be income-tax-free for terminally ill insureds under IRC Section 101(g), but the payout math, caps, and counterparties differ substantially.

How much of my death benefit can I accelerate if I am terminally ill?

It depends entirely on your rider. Terminal-illness provisions commonly allow 25% to 75% of the face amount, with some permitting up to 95%, and many impose separate dollar caps. The check is then reduced by a discount or lien interest reflecting early payment — a short certified life expectancy means a small discount, a longer one means a larger haircut. Request the exact payout figure from your insurer in writing; it is a contractual formula, not an estimate, and you can compare it directly against life settlement offers.

Will taking an accelerated death benefit hurt my Medicaid eligibility?

It can. Accelerated benefit payments that accumulate in your bank account are generally countable resources for Medicaid and SSI, and a lump sum can push you over asset limits and suspend eligibility. Payments applied directly to qualified long-term-care expenses, or structured as periodic payments that are spent as received, may avoid accumulation. Because Medicaid rules are state-administered and include look-back provisions, consult an elder-law attorney or benefits counselor before filing the claim — sequencing the payment correctly is far easier than restoring lost eligibility.

Can I get a life settlement if my policy already has an accelerated death benefit rider?

Yes. Having an ADB rider does not prevent a sale — but using it first usually reduces what buyers will pay, because acceleration shrinks the death benefit they would ultimately collect. The smarter sequence is to obtain both numbers before triggering either: ask your insurer for a written quote of the exact ADB payout, and simultaneously solicit settlement offers through a licensed broker. Policyholders are sometimes surprised by which side wins; chronic conditions with multi-year prognoses often price better in the settlement market than under rider formulas.

Are accelerated death benefits taxable income?

Usually not for terminally ill insureds. IRC Section 101(g) treats amounts received when a physician certifies a life expectancy of 24 months or less as death benefits, which are excluded from income. Chronically ill insureds can also receive benefits tax-free, but generally only when payments cover qualified long-term-care costs or stay within the IRS per-diem limitation. Some critical-illness lump-sum designs fall outside these exclusions. State taxes and individual circumstances vary, so confirm treatment with a tax professional before claiming — and note viatical settlement proceeds can enjoy the same exclusion.

Which pays more, an accelerated death benefit or selling my policy?

There is no universal answer — it turns on your prognosis and the rider’s formula. With a very short certified life expectancy, the ADB’s discount is minimal and can pay close to the accelerated face amount, which is difficult for any buyer to beat. With a chronic condition or a prognosis measured in years, rider formulas discount heavily or exclude you entirely, while competitive bidding among licensed providers prices the policy’s full economics — often producing the larger number. The only reliable method is getting both figures in writing before committing to either.

Does using an accelerated death benefit cancel my life insurance policy?

Usually not. A partial acceleration reduces the death benefit — and typically the premiums — proportionally or by the advance plus interest, but the remaining coverage stays in force for your beneficiaries. Accelerating the maximum allowed, however, can leave only a small residual benefit, and a few designs terminate the policy at full acceleration. A life settlement, by contrast, always ends your interest in the policy: ownership transfers to the buyer entirely. Review your rider’s reduction method — discount, lien, or dollar-for-dollar — so you know exactly what remains.

What is the difference between a chronic illness rider and long-term care insurance?

A chronic illness rider accelerates your life insurance death benefit when you cannot perform two activities of daily living or have severe cognitive impairment — you are spending your own death benefit early, up to the rider’s caps. Standalone long-term care insurance is a separate policy with its own benefit pool that does not reduce any life insurance payout. Riders are cheaper and easier to obtain but offer smaller, capped benefits; some pay only discounted amounts determined at claim time. Neither requires terminal status, but definitions and payout methods differ by contract.

Find out what your policy is worth — free, confidential, no obligation.

A 15-minute educational review covers your eligibility, every alternative, and a realistic view of what each path would net you.

Call (305) 209-7183 · Request a review online →

Table of Contents